MELISSA TUFTS: Open Payments
NPI 1780223479 · PORTLAND, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,299 in 52 payments from 12 companies in 2025. Trend: 2023 $990 · 2024 $1,028 · 2025 $2,299
Travel & lodging: $1,158Food & beverage: $1,140Education: $1
| Company | Payments | Amount |
|---|---|---|
| Edwards Lifesciences Corporation | 27 | $1,740 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 6 | $147 |
| AstraZeneca Pharmaceuticals LP | 7 | $109 |
| ABIOMED | 3 | $98 |
| BridgeBio Pharma, Inc. | 2 | $37 |
| Merck Sharp & Dohme LLC | 1 | $30 |
| PFIZER INC. | 1 | $27 |
| Lilly USA, LLC | 1 | $27 |
| CVRx, Inc. | 1 | $22 |
| Teleflex LLC | 1 | $22 |
Products named: SAPIEN 3 Ultra RESILIA, LifeVest, LOKELMA, Attruby, VERQUVO, Edwards SAPIEN 3 Ultra Transcatheter Heart Valve, ZEPBOUND, Barostim Neo System.
Industry payments across OR — which companies pay providers there.
